Endo International PLC (NASDAQ:ENDP)
| 6.93 Delayed Data As of Jan 22 |  +0.115 / +1.69%Today’s Change | 2.08 Today|||52-Week Range 8.29 | -3.55% Year-to-Date |
Latest ENDP News | Press Releases
| Here's Why Momentum Investors Will Love Endo International (ENDP) Jan 11 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 6.81 |
| Today’s open | 6.69 |
| Day’s range | 6.67 - 6.95 |
| Volume | 229,408 |
| Average volume (3 months) | 4,966,022 |
| Market cap | $1.6B |
Data as of 3:59pm ET, 01/22/2021
Growth & Valuation
| Earnings growth (last year) | +59.44% |
| Earnings growth (this year) | +8.04% |
| Earnings growth (next 5 years) | -14.00% |
| Revenue growth (last year) | -1.11% |
| P/E ratio | NM |
| Price/Sales | 0.36 |
| Price/Book | -- |
Competitors
| ---- | ||
| SUPNSupernus Pharmaceuti... | +1.58 | +5.57% |
| CNSTConstellation Pharma... | -0.45 | -1.30% |
| HSKAHeska Corp | +1.59 | +0.97% |
Data as of 4:00pm ET, 01/22/2021
Financials
| Next reporting date | March 2, 2021 |
| EPS forecast (this quarter) | $0.44 |
| Annual revenue (last year) | $2.9B |
| Annual profit (last year) | -$422.6M |
| Net profit margin | -12.37% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
